the aid library

LIST OPTIONS

Filter

2333

The rising burden of non-communicable diseases in the Americas and the impact of population aging: a secondary analysis of available data

Hambleton, I. R.; Caixeta, R.; Jeyaseelan, S.M.; et al. The Lance Regional Health America (2023) CC2

The article "The Rising Burden of Non-Communicable Diseases in the Americas and the Impact of Population Aging" examines how the aging population in the Americas is contributing to the growing burden of non-communicable diseases (NCDs), despite improvements in disease ... and health care. Using data from the World Health Organization and the United Nations, the study analyzes trends in population growth, aging, and NCD-related mortality and disability rates from 2000 to 2019 across 33 countries. more

Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs)

Caprara, G. Multidisciplinary Digital Publishing Institute (MDPI) (2021) CC

The uploaded document explores the Mediterranean diet and physical activity as effective strategies to prevent and manage non-communicable diseases (NCDs). It discusses the diet's nutritional components, such as olive oil, fruits, and vegetables, and their health benefits, including reduced risk of ... more

Unhealthy Dietary Habits and Obesity: The Major Risk Factors Beyond Non-Communicable Diseases in the Eastern Mediterranean Region

Al-Jawaldeh, A.; Abbass, M.M. Frontiers in Nutrition (2022) CC

The article examines the nutritional and lifestyle-related risk factors contributing to the prevalence of non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and cancer in the Eastern Mediterranean Region (EMR). It highlights... more

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease

Institute for Health Metrics and Evaluation - University of Washington The Lancet (2017) CC2

The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a ... more

Noncommunicable diseases - Key facts

World Health Organization (WHO) World Health Organization (WHO) (2024) C_WHO

The World Health Organization's Global Health Observatory (GHO) provides comprehensive data on noncommunicable diseases (NCDs), including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. The portal offers country-specific statistics on NCD mortality rates, risk factors, ... more

Noncommunicable diseases - Regional framework for action

World Health Organization (WHO) Regional Office for the Eastern Mediterranean World Health Organization (WHO) Regional Office for the Eastern Mediterranean (2024) C_WHO

The WHO EMRO webpage on the "Regional framework for action" outlines strategies for addressing noncommunicable diseases (NCDs) within the Eastern Mediterranean region. The framework provides a roadmap for countries to reduce the prevalence and impact of NCDs such as cardiovascular diseases, diabetes... more

Air pollution: the emergence of a major global health risk factor

Boogard, H.; Walker, K.; Cohen, A.J. International Health (2019) CC

The article "Air Pollution: The Emergence of a Major Global Health Risk Factor" discusses the significant health impacts of air pollution, a leading risk factor for global mortality. It highlights the adverse effects of fine particulate matter (PM2.5) and tropospheric ozone, linking them to cardiova... more

Noncommunicable diseases country profiles 2018 WHO

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO

The Noncommunicable Diseases Country Profiles 2018 by the World Health Organization (WHO) provides an in-depth look at the burden of noncommunicable diseases (NCDs) such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes ... more

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 1: conducting a comprehensive assessment

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi... more

Household air pollution - WHO

World Health Organisation (WHO) World Health Organization (WHO) (2023) C_WHO

The World Health Organization (WHO) highlights the significant health risks associated with household air pollution, primarily resulting from the use of inefficient and polluting fuels and technologies for cooking, heating, and lighting. In 2020, approximately 2.1 billion people—about one-third of... more

Download (289)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1940)

View PDF (1867)

Cancer
recommended

Hellen Gelband,Jha Prabhat, Rengaswamy Sankaranarayanan et al. The World Bank (2015) C1

This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of ... will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings. Disease Control Priorities, Third Edition: Volume 3 more

Download (291)

View PDF (555)

Operational Framework Management of Common Cancer

Ministry of Health & Family Welfare, India (2016) C1

External Link

Injury Prevention and Environmental Health. Disease Control Priorities, Third Edition : Volume 7

Mock, Charles N.; Nugent, Rachel; Kobusingye, Olive; et al. World Bank (2017) CC

The substantial burden of death and disability that results from interpersonal violence, road traffic injuries, unintentional injuries, occupational health risks, air pollution, climate change, and inadequate water and sanitation falls disproportionally on low- and middle-income countries. Injury ... and Environmental Health addresses the risk factors and presents updated data on the burden, as well as economic analyses of platforms and packages for delivering cost-effective and feasible interventions in these settings. The volume's contributors demonstrate that implementation of a range of prevention strategies-presented in an essential package of interventions and policies-could achieve a convergence in death and disability rates that would avert more than 7.5 million deaths a year more

Download (937)

View PDF (1268)

National Strategy for Cancer Control in Ghana 2012-2016

Ministry of Health, Ghana (2011) C1

Kenya: National Cancer Control Strategy 2017-2022

Ministry of Health, Kenya (2017) C1

Download (1346)

View PDF (1992)

Training of community health workers: Cervical cancer screening and management of cervical pre-cancers

Lakhbir Dhaliwal, Vanita Suri, Reshmi Bagga et al. World Health Organisation (WHO) (2017) C_WHO

Cervical cancer is the second most common cancer among women worldwide and causes a significant number of deaths in the South-East Asia Region. Nearly 200 000 new cases of cervical ... occurred in SEA Region Member States in 2008, giving an incidence of almost 25 per 100 000 and a mortality rate of almost 14 per 100 000. Cervical cancer can be prevented by early screening and vaccination. However, due to poor access to screening and treatment services, the vast majority of these deaths occur in women from nine Member States of the South-East Asia Region which account for more than one third of the global burden of cervical cancer. more

Download (344)

View PDF (565)

Weak surveillance and policy attention to cancer in global health: the example of Mozambique

Lorenzoni, C; Oliveras, Laura; Vilajeliu, A, et al. (2018) CC

Cancer is an emerging public health problem in sub-Saharan Africa due to population growth, ageing and westernisation of lifestyles. In this piece, we use data from Mozambique over a 50-year period to illustrate ... epidemiological trends in low-income and middle-income countries to hypothesise potential circumstances and factors that could explain changes in cancer burden and to discuss surveillance weaknesses and potential improvements. This epidemiological transition deserves increasing policy attention. more

Clinical guidelines for breast cancer control and managment

Ministry of Health, Republic of South Africa (2018) CC

Download (361)

View PDF (386)

Women Cancer
recommended

Henke, A.; and S. Mauder The MEDBOX Team (2021) CC

MEDBOX Issue Brief No.17, 21 November 2021 Women's cancers have a significant impact on women's health worldwide. According to the World Health Organisation, nearly three million women are diagnosed with breast or cervical cancer every year. In th... more

Cancer recommended

Women Cancer recommended

Cancer
recommended

Women Cancer
recommended